Array Biopharma (ARRY) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Array Biopharma (ARRY) Tops Q1 EPS by 3c

Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2016

November 4, 2015 8:03 AM EST

BOULDER, Colo., Nov. 4, 2015 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the first quarter of its fiscal year ending June 30, 2016 and provided an update on progress on its key clinical development programs.

Ron Squarer, Chief Executive Officer of Array, noted, "The first quarter has been a period of important progress as we continue to advance binimetinib and encorafenib, two innovative oncology products in Phase 3, toward 2016 regulatory submissions.  Recently presented data supports the value of our BRAF-mutant melanoma and BRAF-mutant... More